Growth Metrics

Palisade Bio (PALI) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Palisade Bio 439.25 Mn 309.68 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -75.00%
Mar 31, 2025 -60.00%
Dec 31, 2024 -70.00%
Sep 30, 2024 -70.00%
Jun 30, 2024 -63.64%
Mar 31, 2024 -44.44%
Dec 31, 2023 0.00%
Sep 30, 2023 -16.67%
Jun 30, 2023 450.00%
Mar 31, 2023 350.00%
Dec 31, 2022 233.33%
Sep 30, 2022 300.00%
Jun 30, 2022 -33.33%
Mar 31, 2022 -72.39%
Dec 31, 2021 -40.00%
Sep 30, 2021 -80.05%
Jun 30, 2021 -86.17%
Mar 31, 2021 -76.73%
Dec 31, 2020 -87.82%
Sep 30, 2020 -71.05%
Jun 30, 2020 -65.80%
Mar 31, 2020 -58.86%
Dec 31, 2019 -54.56%
Sep 30, 2019 -51.52%
Jun 30, 2019 -50.44%
Mar 31, 2019 -49.44%
Dec 31, 2018 -47.76%
Sep 30, 2018 -45.38%
Jun 30, 2018 -41.65%
Mar 31, 2018 -38.36%
Dec 31, 2017 -35.86%
Sep 30, 2017 -37.82%
Jun 30, 2017 -39.60%
Mar 31, 2017 -27.94%
Dec 31, 2016 -21.46%
Sep 30, 2016 -6.05%
Jun 30, 2016 5.90%
Mar 31, 2016 19.47%
Dec 31, 2015 13.92%
Sep 30, 2015 11.48%
Jun 30, 2015 10.62%
Mar 31, 2015 -9.12%
Dec 31, 2014 30.43%
Sep 30, 2014 18.82%
Jun 30, 2014 63.34%
Mar 31, 2014 49.44%
Dec 31, 2013 0.25%
Sep 30, 2013 3.07%
Jun 30, 2013 -29.56%
Mar 31, 2013 -22.04%
Dec 31, 2012 -21.15%
Sep 30, 2012 -21.23%
Jun 30, 2012 -19.75%
Dec 31, 2011 46.04%